Blog dermatologico
Elenco degli articoli nella categoria «Ricerca»
2020
The 2020 International Alliance for the Control of Scabies
RicercaConsensus Criteria for the Diagnosis of Scabies...
Leggi tutto2020
2020
Clinical and Dermoscopic Features of Vulvar Melanosis Over the Last 20 Years
RicercaIn this cohort study of 129 patients with vulvar melanosis and 5 to 20 years of follow-up, 67% of vulvar melanotic lesions appeared in premenopausal patients, and 65% of all patients had received some type of hormone therapy;...
Leggi tutto2020
Characteristic of Chronic Plaque Psoriasis Patients Treated with Biologics in Italy during the COVID-19 Pandemic
RicercaRisk Analysis from the PSO-BIO-COVID Observational Study...
Leggi tutto2020
Autoimmunity in Segmental Vitiligo
RicercaThe autoimmune basis of segmental vitiligo (SV) has only recently been recognized....
Leggi tutto2020
Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and Abrocitinib
RicercaAtopic dermatitis is a common, chronic, immune-mediated disease associated with several comorbidities....
Leggi tutto2020
DIAGNOSTIC ACCURACY OF DERMOSCOPY OF ACTINIC KERATOSIS: A SYSTEMATIC REVIEW
RicercaDermoscopy is a tool that aids clinicians in the diagnosis of actinic keratosis;...
Leggi tutto2020
Cutaneous Melanoma Arising in Congenital Melanocytic Nevus
RicercaA Retrospective Observational Study...
Leggi tutto2020
5‐Alpha‐Reductase Inhibitors are Associated with Reduced Frequency of COVID‐19 Symptoms in Males with Androgenetic Alopecia
RicercaWe have previously reported that men with androgenetic alopecia (AGA) are more likely to present with severe COVID‐19 symptoms, potentially implicating androgen sensitivity as a risk factor for COVID‐19....
Leggi tutto2020
Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis
RicercaReal‐world effectiveness and tolerability of dupilumab in adult atopic dermatitis: A single centre, prospective one‐year observational cohort study of the first 100 patients treated...
Leggi tutto2020
Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale
RicercaIncidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma...
Leggi tutto2020
Special aspects of biologics treatment in psoriasis: management in pregnancy, lactation, surgery, renal impairment, hepatitis and tuberculosis
RicercaBiologics are modern immunomodulatory drugs, whose use in the treatment of psoriasis has led to remarkable results in psoriatic patients. The administration of these agents in special population groups, such as patients with chronic in...
Leggi tutto2020
Analysis of cutaneous Merkel cell carcinoma outcomes after different surgical interventions
RicercaCurrent guidelines recommend local excision margin (EM) with 1 to 2 cm on primary Merkel cell carcinoma (MCC) sites....
Leggi tutto2020
Daylight photodynamic therapy of actinic keratosis without curettage is as effective as with curettage: a randomized clinical trial
RicercaGuidelines for photodynamic therapy (PDT) of actinic keratosis (AK) recommend pretreatment with curettage. The impact of curettage on cure rate is, however, not well established....
Leggi tutto2020
Cutaneous adverse reactions to anti–PD-1 treatment. A systematic review
RicercaA systematic review...
Leggi tutto2020
Expanding treatment options for rosacea
RicercaSuch a high-quality cluster randomized controlled trial involving 2040 nurses across the UK....
Leggi tutto2020
2020
Immunogenicity of biologic therapies in psoriasis Myths, facts and a suggested approach
RicercaWith biologic drugs dominating the therapeutic space for severe immune‐mediated inflammatory disease, it is critical for clinicians to be familiar with the concept of drug immunogenicity, with the potential for our patients to develo...
Leggi tutto2020
Long‐term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients
RicercaDupilumab, an inhibitor of interleukin (IL)‐4/13 activity, is a biological agent approved for the treatment of moderate‐to‐severe atopic dermatitis (AD)...
Leggi tutto2020
Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis
RicercaIs exposure to topical calcineurin inhibitors among adult patients with atopic dermatitis associated with increased keratinocyte carcinoma risk?...
Leggi tutto